Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Verve Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 121 | 134 | +13 |
| Shares | 61.9M | 63.9M | +1.99M (+3.2%) |
| Value | $1.16B | $847.0M | −$313.3M (−27.0%) |
New holders (27)
Institutions that held Verve Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (14)
Institutions that held Verve Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Novo Holdings A/S | 500,000 | $9.38M |
| PFM Health Sciences, LP | 186,087 | $3.49M |
| Jefferies Financial Group Inc. | 177,716 | $3.33M |
| Marshall Wace, LLP | 51,235 | $960.7K |
| Verition Fund Management LLC | 27,153 | $509.1K |
| Hudson Bay Capital Management LP | 22,500 | $421.9K |
| HRT Financial LP | 12,669 | $237.0K |
| Dynamic Technology Lab Private Ltd | 11,051 | $207.0K |
| Qube Research & Technologies Ltd | 10,224 | $191.7K |
| Caption Management, LLC | 5,700 | $106.9K |
| Point72 Asset Management, L.P. | 3,250 | $60.9K |
| Simplex Trading, LLC | 324 | $6.00K |
| Russell Investments Group, Ltd. | 23 | $431 |
| Motco | 1 | $19 |